Navigation Links
Analysis Finds BYETTA® Associated with Lower Likelihood of Heart Failure Compared with Other Diabetes Therapies: Results Presented at ADA 2011
Date:6/24/2011

SAN DIEGO, June 24, 2011 /PRNewswire/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Eli Lilly and Company (NYSE: LLY) today announced results from a retrospective analysis of more than 778,000 patients that showed the addition of BYETTA® (exenatide) injection to pre-existing diabetes treatment regimens was associated with a reduced likelihood of heart failure, especially among patients receiving insulin. These findings will be presented in a poster session at the 71st Scientific Sessions of the American Diabetes Association in San Diego on June 25 from 11:30 a.m. to 1:30 p.m. PDT.

The retrospective analysis used data from the GE Healthcare Centricity electronic medical record to analyze the likelihood of heart failure for BYETTA in combination with certain other diabetes treatments compared with control groups of patients not treated with BYETTA. Across all therapies, patients who received BYETTA were 54 percent less likely to experience heart failure compared to patients not treated with BYETTA.

"Compared with the general population, people with diabetes have an increased risk of heart disease, with at least double the risk of developing heart failure. That's why it is imperative that we understand the role diabetes treatments may play in patients' cardiovascular health," said Christian Weyer, M.D., senior vice president, research and development, Amylin Pharmaceuticals. "In addition to retrospective analyses like this one, our EXSCEL cardiovascular outcomes study is underway to thoroughly and prospectively evaluate cardiovascular effects of exenatide."

EXSCEL (EXenatide Study of Cardiovascular Event Lowering) is designed to determine if there are favorable cardiovascular effects of exenatide treatment, using BYDUREON™ (exenatide extended-relea
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.; Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis
2. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
3. New Data From Large Safety Analysis of MYCAMINE Shows Favorable Clinical Safety Profile
4. Immtech Announces Interim Analysis in Phase III African Sleeping Sickness Trial
5. Analysis Shows Vernakalant Hydrochloride Injection Increases Conversion to Normal Heart Rhythm in Acute Atrial Fibrillation Patients Treated Within 48 Hours of Onset
6. New Analysis of Study Data Shows That Asacol(R) (Mesalamine) Delivers Rapid Symptom Relief for Ulcerative Colitis Patients
7. A Sociolinguistic Analysis of In-Office Dialogue Reveals Psychiatrists and Parents Have Significantly Different Perceptions on ADHD and Psychiatric Comorbidities
8. Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results
9. Results Of VYVANSE(TM) (lisdexamfetamine dimesylate) Effect Size Analysis Presented at Major Scientific Meeting
10. Progen Presents Additional Analysis of Data from PI-88 Phase 2 Liver Cancer Study at American Association for the Study of Liver Diseases
11. Retrospective Analysis Finds That Initiation of Insulin Glargine in Patients With Type 2 Diabetes was Associated With a Lower Incidence Rate of Myocardial Infarction as Compared With NPH Insulin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... Tandem Diabetes Care®, Inc. (NASDAQ: TNDM ), a ... today reported its financial results for the quarter ended June ... of 2014 to the same period of 2013: , ... , t:slim Pump shipments grew 64 percent to 2,235 ... ended June 30, 2014 to the same period of 2013: ...
(Date:7/31/2014)... SUNNYVALE, Calif. , July 31, 2014  Cepheid (NASDAQ: ... be speaking at the following conferences, and invited investors to ... Management Access Conference, New York, NY ... Baird Health Care Conference, New York, ... Eastern Time , Accessing Live Webcasts To access ...
(Date:7/31/2014)... --  Auxilium Pharmaceuticals , Inc. (NASDAQ: AUXL ... that the Company will release results for the second ... the opening of the U.S. financial markets. The Company ... 8:30 a.m. ET to discuss results and highlights of ... be used during the call will be available on ...
Breaking Medicine Technology:Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 2Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 3Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 4Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 5Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 6Cepheid to Webcast Upcoming Financial Presentations 2Auxilium Pharmaceuticals, Inc. To Announce Second Quarter 2014 Results On August 7, 2014 2Auxilium Pharmaceuticals, Inc. To Announce Second Quarter 2014 Results On August 7, 2014 3
... 22 CardioVascular,BioTherapeutics, Inc. (OTC Bulletin Board: CVBT) has ... be the sponsor and general,partner of ProDerm Limited Partnership ... up to $10 million of the clinical development for ... with CVBT,s wound healing drug, which I,believe has the ...
... Analysis of rEEG(R) Guided Medication Study Demonstrates an ... Improvement in Depression and Eating Disorder Symptoms, ... Inc.,(OTC Bulletin Board: CNSO) reported today the results ... (APA) 161st Annual Meeting by Dr.,James Greenblatt, M.D., ...
Cached Medicine Technology:Dr. Christopher Moore to Form ProDerm LP to Fund CVBT Wound Healing Trial 2Dr. Christopher Moore to Form ProDerm LP to Fund CVBT Wound Healing Trial 3CNS Response, Inc. Provides Review of Poster Session Delivered at the American Psychiatric Association 161st Annual Meeting 2CNS Response, Inc. Provides Review of Poster Session Delivered at the American Psychiatric Association 161st Annual Meeting 3CNS Response, Inc. Provides Review of Poster Session Delivered at the American Psychiatric Association 161st Annual Meeting 4CNS Response, Inc. Provides Review of Poster Session Delivered at the American Psychiatric Association 161st Annual Meeting 5CNS Response, Inc. Provides Review of Poster Session Delivered at the American Psychiatric Association 161st Annual Meeting 6
(Date:8/1/2014)... 2014 A new study published ... may contribute to the development of colorectal cancer in ... The study was authored by Alberto Martin of the ... cause intestinal cells to multiply and create tumors in ... , “What’s interesting about this study,” said Shahab ...
(Date:8/1/2014)... BellasDress has recently showcased its beautifully ... season’s gorgeous styles. The company’s lot of hot styles, ... outfits, one shoulder chiffon outfits and high low outfits. ... elegant purple prom dresses. As one of the most ... product quality. Thus, all its items are of superb ...
(Date:8/1/2014)... HealthDay Reporter THURSDAY, July 31, 2014 (HealthDay ... has a well-earned reputation as one of the world,s most ... medical care can greatly improve a person,s chances of survival. ... life-threatening havoc within the body by attacking multiple organ systems ... on the basics of "good meticulous intensive care," supporting the ...
(Date:8/1/2014)... For the first time, Textile ... & Fiber Report and the Organic Cotton Market Report ... cotton supply chain resulting in the 2013 Organic ... Director, reports, “We are looking holistically at the organic ... of a long value chain and surveying the entire ...
(Date:8/1/2014)... (PRWEB) August 01, 2014 “When insulation ... throughout your entire home.“ In a newly released article ... Attic Insulation Needs To Be Replaced ,” Clean Crawls ... become damp, or been infested by critters. , ... quote from Clean Crawls - http://www.cleancrawl.com/contact . , ...
Breaking Medicine News(10 mins):Health News:Carbs May Contribute to Colon Cancer 2Health News:BellasDress Creates Must-have Purple Prom Dresses for Prom Attendees 2Health News:There's No Ebola Cure, But Early Intensive Treatment Boosts Survival 2Health News:There's No Ebola Cure, But Early Intensive Treatment Boosts Survival 3Health News:Surveys Reveal the Top 10 Organic Cotton Users and the Top 10 Producing Countries 2Health News:5 Signs That Insulation Should Be Replaced Detailed in a Newly Released Article By Clean Crawls 2
... TUESDAY, Jan. 25 (HealthDay News) -- There,s a worrisome uptick in ... even younger Americans, and some experts link the trend to a ... decades. That,s because the human papillomavirus (HPV) is a major ... type of sexual activity. "It seems like a pretty ...
... study, which was conducted at Sahlgrenska University Hospital in ... between the ages of 18 and 65. Half the ... and the other half to maintain their usual lifestyle. ... physiotherapist. The active group increased their physical activity on ...
... French researchers determined that infection with human immunodeficiency ... liver cancer, with more HIV infected patients dropping ... that overall survival and recurrence-free survival was not ... HIV disease. Details of this single center studythe ...
... HealthDay Reporter , MONDAY, Jan. 24 (HealthDay News) ... become the healthiest, wealthiest and most successful adults, new research ... 3 are more likely to drop out of school, break ... Researchers analyzed data on about 1,000 children born in ...
... As keyboards increasingly replace pens, new research cautions that the ... critical brain activity central to learning that is uniquely tied ... from the results of a number of experiments recently reviewed ... concluded that writing by hand is actually a very different ...
... Association of Clinical Endocrinologists (AACE) has released new medical ... Loyola physician Pauline Camacho, MD, was part of a ... public health issue. These recommendations were developed to ... quality of life for patients. They explain new treatment ...
Cached Medicine News:Health News:Rise in Some Head and Neck Cancers Tied to Oral Sex: Study 2Health News:Rise in Some Head and Neck Cancers Tied to Oral Sex: Study 3Health News:Rise in Some Head and Neck Cancers Tied to Oral Sex: Study 4Health News:Patients infected with HIV have higher drop-out rate for liver transplantation 2Health News:Self-Control Could Turn Kids Into Successful Adults 2Health News:Self-Control Could Turn Kids Into Successful Adults 3Health News:Pen Mightier Than Keyboard for Making Imprint on Brain 2Health News:Loyola physician helps develop national guidelines for osteoporosis 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: